Zepbound: A New GLP-1 Option for Weight & Sleep Apnea

GLP-1 (glucagon-like peptide-1) medications were first designed for diabetes, but their benefits go far beyond blood sugar control. Zepbound is a new GLP-1 treatment approved for adults who are overweight or obese — even if they don’t have diabetes. What makes Zepbound unique is that it’s the only GLP-1 medication approved to treat obstructive sleep apnea (OSA), especially for patients who struggle with CPAP therapy. By reducing weight and improving metabolic health, it can also help improve sleep quality. Who may benefit? 1) Adults with obesity (BMI ≥30) 2) Adults with overweight (BMI ≥27) plus a health condition (like high blood pressure, diabetes, or sleep apnea) 3) Adults with OSA who cannot tolerate CPAP. Zepbound isn’t a quick fix, but it’s an exciting new option to treat weight and sleep apnea as medical conditions, not just lifestyle issues. 👉 Talk with your healthcare provider to see if Zepbound is right for you.

SLEEP